Global Generics
Global Generics
SUMMARY
Global Generics industry profile provides top-line qualitative and quantitative summary information including: market size (value and volume 2015-19, and forecast to 2024). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.
KEY HIGHLIGHTS
SUMMARY
Global Generics industry profile provides top-line qualitative and quantitative summary information including: market size (value and volume 2015-19, and forecast to 2024). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.
KEY HIGHLIGHTS
- For the purposes of this profile, a generic drug is defined as a copy of an ethical (prescription) drug formerly protected by patents that have now expired. Both unbranded generics and all branded generics are included. However, off-patent drugs that continue to be offered by the original manufacturer under the original name, and which form part of the 'generic-eligible' market, are not included.
- The global generics market had total revenues of $339.2bn in 2019, representing a compound annual growth rate (CAGR) of 6.1% between 2015 and 2019.
- Market consumption volume increased with a CAGR of 2.4% between 2015 and 2019, to reach a total of 54.6% in 2019.
- Asia-Pacific accounts for 38.3% of the global market value whilst Europe and the US make up 22.1% and 32.1% respectively.
- Save time carrying out entry-level research by identifying the size, growth, and leading players in the generics market in the global
- Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the globalgenerics market
- Leading company profiles reveal details of key generics market players’ global operations and financial performance
- Add weight to presentations and pitches by understanding the future growth prospects of the Global generics market with five year forecasts by both value and volume
- What was the size of the Global generics market by value in 2019?
- What will be the size of the Global generics market in 2024?
- What factors are affecting the strength of competition in the Global generics market?
- How has the market performed over the last five years?
- How large is the global’s generics market in relation to its regional counterparts?
1 EXECUTIVE SUMMARY
1.1. Market value
1.2. Market value forecast
1.3. Market volume
1.4. Market volume forecast
1.5. Geography segmentation
1.6. Market rivalry
1.7. Competitive Landscape
2 MARKET OVERVIEW
2.1. Market definition
2.2. Market analysis
3 MARKET DATA
3.1. Market value
3.2. Market volume
4 MARKET SEGMENTATION
4.1. Geography segmentation
5 MARKET OUTLOOK
5.1. Market value forecast
5.2. Market volume forecast
6 FIVE FORCES ANALYSIS
6.1. Summary
6.2. Buyer power
6.3. Supplier power
6.4. New entrants
6.5. Threat of substitutes
6.6. Degree of rivalry
7 COMPETITIVE LANDSCAPE
7.1. Who are the leading players?
7.2. What are the strengths of the leading players?
7.3. Has there been any significant recent M&A activity?
7.4. How has the outbreak of COVID-19 impacted leading players?
8 COMPANY PROFILES
8.1. Teva Pharmaceutical Industries Limited
8.2. Pfizer Inc.
8.3. Sun Pharmaceutical Industries Ltd
8.4. Pfizer Inc.
9 MACROECONOMIC INDICATORS
9.1. Country data
10 APPENDIX
10.1. Methodology
10.2. Industry associations
10.3. Related MarketLine research
10.4. About MarketLine
1.1. Market value
1.2. Market value forecast
1.3. Market volume
1.4. Market volume forecast
1.5. Geography segmentation
1.6. Market rivalry
1.7. Competitive Landscape
2 MARKET OVERVIEW
2.1. Market definition
2.2. Market analysis
3 MARKET DATA
3.1. Market value
3.2. Market volume
4 MARKET SEGMENTATION
4.1. Geography segmentation
5 MARKET OUTLOOK
5.1. Market value forecast
5.2. Market volume forecast
6 FIVE FORCES ANALYSIS
6.1. Summary
6.2. Buyer power
6.3. Supplier power
6.4. New entrants
6.5. Threat of substitutes
6.6. Degree of rivalry
7 COMPETITIVE LANDSCAPE
7.1. Who are the leading players?
7.2. What are the strengths of the leading players?
7.3. Has there been any significant recent M&A activity?
7.4. How has the outbreak of COVID-19 impacted leading players?
8 COMPANY PROFILES
8.1. Teva Pharmaceutical Industries Limited
8.2. Pfizer Inc.
8.3. Sun Pharmaceutical Industries Ltd
8.4. Pfizer Inc.
9 MACROECONOMIC INDICATORS
9.1. Country data
10 APPENDIX
10.1. Methodology
10.2. Industry associations
10.3. Related MarketLine research
10.4. About MarketLine
LIST OF TABLES
Table 1: Global generics market value: $ billion, 2015-19
Table 2: Global generics market volume: % of total pharma, 2015-19
Table 3: Global generics market geography segmentation: $ billion, 2019
Table 4: Global generics market value forecast: $ billion, 2019-24
Table 5: Global generics market volume forecast: % of total pharma, 2019-24
Table 6: Teva Pharmaceutical Industries Limited: key facts
Table 7: Teva Pharmaceutical Industries Limited: Annual Financial Ratios
Table 8: Teva Pharmaceutical Industries Limited: Key Employees
Table 9: Pfizer Inc.: key facts
Table 10: Pfizer Inc.: Annual Financial Ratios
Table 11: Pfizer Inc.: Key Employees
Table 12: Pfizer Inc.: Key Employees Continued
Table 13: Sun Pharmaceutical Industries Ltd: key facts
Table 14: Sun Pharmaceutical Industries Ltd: Annual Financial Ratios
Table 15: Sun Pharmaceutical Industries Ltd: Key Employees
Table 16: Pfizer Inc.: key facts
Table 17: Pfizer Inc.: Annual Financial Ratios
Table 18: Pfizer Inc.: Key Employees
Table 19: Pfizer Inc.: Key Employees Continued
Table 20: Global exchange rate, 2015-19
Table 1: Global generics market value: $ billion, 2015-19
Table 2: Global generics market volume: % of total pharma, 2015-19
Table 3: Global generics market geography segmentation: $ billion, 2019
Table 4: Global generics market value forecast: $ billion, 2019-24
Table 5: Global generics market volume forecast: % of total pharma, 2019-24
Table 6: Teva Pharmaceutical Industries Limited: key facts
Table 7: Teva Pharmaceutical Industries Limited: Annual Financial Ratios
Table 8: Teva Pharmaceutical Industries Limited: Key Employees
Table 9: Pfizer Inc.: key facts
Table 10: Pfizer Inc.: Annual Financial Ratios
Table 11: Pfizer Inc.: Key Employees
Table 12: Pfizer Inc.: Key Employees Continued
Table 13: Sun Pharmaceutical Industries Ltd: key facts
Table 14: Sun Pharmaceutical Industries Ltd: Annual Financial Ratios
Table 15: Sun Pharmaceutical Industries Ltd: Key Employees
Table 16: Pfizer Inc.: key facts
Table 17: Pfizer Inc.: Annual Financial Ratios
Table 18: Pfizer Inc.: Key Employees
Table 19: Pfizer Inc.: Key Employees Continued
Table 20: Global exchange rate, 2015-19
LIST OF FIGURES
Figure 1: Global generics market value: $ billion, 2015-19
Figure 2: Global generics market volume: % of total pharma, 2015-19
Figure 3: Global generics market geography segmentation: % share, by value, 2019
Figure 4: Global generics market value forecast: $ billion, 2019-24
Figure 5: Global generics market volume forecast: % of total pharma, 2019-24
Figure 6: Forces driving competition in the global generics market, 2019
Figure 7: Drivers of buyer power in the global generics market, 2019
Figure 8: Drivers of supplier power in the global generics market, 2019
Figure 9: Factors influencing the likelihood of new entrants in the global generics market, 2019
Figure 10: Factors influencing the threat of substitutes in the global generics market, 2019
Figure 11: Drivers of degree of rivalry in the global generics market, 2019
Figure 1: Global generics market value: $ billion, 2015-19
Figure 2: Global generics market volume: % of total pharma, 2015-19
Figure 3: Global generics market geography segmentation: % share, by value, 2019
Figure 4: Global generics market value forecast: $ billion, 2019-24
Figure 5: Global generics market volume forecast: % of total pharma, 2019-24
Figure 6: Forces driving competition in the global generics market, 2019
Figure 7: Drivers of buyer power in the global generics market, 2019
Figure 8: Drivers of supplier power in the global generics market, 2019
Figure 9: Factors influencing the likelihood of new entrants in the global generics market, 2019
Figure 10: Factors influencing the threat of substitutes in the global generics market, 2019
Figure 11: Drivers of degree of rivalry in the global generics market, 2019